Y2E-12663-84671
3 vaccinations
3 coded responses
40 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 486 / MI
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-15
Registered in v-safe
-
2021-06-15
Dose 1 — Pfizer-BioNTech
- 2021-06-15
- 2021-06-16
- 2021-06-17
- 2021-06-18
- 2021-06-19
- 2021-06-20
- 2021-06-21
- 2021-06-22
- 2021-06-29
-
2021-07-07
Dose 2 — Pfizer-BioNTech
- 2021-07-07
- 2021-07-08
- 2021-07-09
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-21
- 2021-07-28
- 2021-08-04
- 2021-08-11
- 2021-08-18
- 2021-10-06
- 2022-01-05
-
2022-01-10
Dose 3 — Pfizer-BioNTech
- 2022-01-10
-
2022-01-11
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-01-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-01-13
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2022-01-16
- 2022-01-17
- 2022-01-24
- 2022-01-31
-
2022-02-07
Survey response — day 28, dose 3MedDRA: Sinusitis — Feeling: FairFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
- 2022-02-14
- 2022-02-21
- 2022-04-11
-
2022-07-14
Survey response — 6 months, dose 3MedDRA: Ear infection, Upper respiratory tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory infection and ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-15
Call successfulParticipant prefers to complete VAERS report online
- 2023-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-15 | Pfizer-BioNTech | |
| 2 | 2021-07-07 | Pfizer-BioNTech | No |
| 3 | 2022-01-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-14 | Successful 2022-07-15 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Runny nose
Release 11 — day 28, dose 3
Symptoms: Sinus infection
Release 12 — 6 months, dose 3
Symptoms: Upper respiratory infection and ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear infection | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release